148 Recruiting Bladder Cancer Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Bladder Cancer
Related Conditions
Top Recruiting Bladder Cancer Studies
Study of CAbozantinib in Combination with AtezolizumaB for Muscle-Invasive BladdEr Cancer
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder Cancer
📍 Tom Baker Cancer Centre — Calgary, Alberta
View Study & Checklist ➔Determinants of Bladder Cancer Recurrence Study (The DETER Study)
📍 Memorial Sloan Kettering Cancer Center — Basking Ridge, New Jersey
View Study & Checklist ➔Quality of Life in Patients With Bladder Cancer
📍 Memorial Sloan-Kettering Cancer Center — New York, New York
View Study & Checklist ➔A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer
📍 Hartford Healthcare Cancer Institute @ Hartford Hospital — Hartford, Connecticut
View Study & Checklist ➔A Diagnostic for the Early Detection of Bladder Cancer
📍 Long Beach VA Healthcare System — Long Beach, California
View Study & Checklist ➔Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium
📍 University of Texas MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Adjuvant Nivolumab Following Chemo-Radiation in Localized Muscle-Invasive Bladder Cancer
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔CISTO: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Molecular Analysis Of Bladder Cancer
📍 Lahey Clinic — Burlington, Massachusetts
View Study & Checklist ➔A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
📍 Arizona Urology Specialists — Tucson, Arizona
View Study & Checklist ➔A Window of Opportunity Phase I Study of UGN-201 in Patients With Bladder Cancer Undergoing Radical Cystectomy Protocol #: 2021-0630
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer
📍 Alaska Clinical Research Center — Anchorage, Alaska
View Study & Checklist ➔A Novel Multiplex ELISA Assay for Evaluating Patients With Gross Hematuria for Bladder Cancer
📍 Cedars-Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)
📍 City of Hope — Duarte, California
View Study & Checklist ➔Evaluating Bladder CARE™, a New Non-Invasive Urine Test, for Bladder Cancer Detection in Inconclusive Cases
📍 Mayo Clinic — Rochester, Minnesota
View Study & Checklist ➔Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)
📍 University of California San Francisco — San Francisco, California
View Study & Checklist ➔(CLONEVO): Cell cycLe inhbitiON to Target the EVolution of UrOthelial Cancer
📍 Weill Cornell Medicine — New York, New York
View Study & Checklist ➔Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer
📍 Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina
View Study & Checklist ➔A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005)
📍 UCLA Hematology/Oncology - Westwood (Building 200 Suite 140)-Department of Urology/Institute of Uro ( Site 0104) — Los Angeles, California
View Study & Checklist ➔Computed Tomography Urography (CTU) vs Intravenous Urography (IVU) on Patients at Risk of Urothelial Tumors
📍 University of Texas MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Genetic Susceptibility to Bladder Cancer
📍 Baylor College of Medicine — Houston, Texas
View Study & Checklist ➔A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer
📍 Loma Linda University Medical Center — Loma Linda, California
View Study & Checklist ➔Intravenous (IV) Vitamin C With Chemotherapy for Cisplatin Ineligible Bladder Cancer Patients
📍 The University of Kansas Cancer Center (KUCC) — Fairway, Kansas
View Study & Checklist ➔Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-Eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)
📍 Mayo Clinic in Arizona - Phoenix ( Site 0043) — Phoenix, Arizona
View Study & Checklist ➔A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC)
📍 Mayo Clinic — Scottsdale, Arizona
View Study & Checklist ➔Pembrolizumab (MK-3475) and Bacillus Calmette-Guérin (BCG) as First-Line Treatment for High-Risk T1 Non-Muscle-Invasive Bladder Cancer (NMIBC) and High-Grade Non-Muscle-Invasive Upper Tract Urothelial Carcinoma (NMI-UTUC)]
📍 Memorial Sloan Kettering Basking Ridge (All Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔A Study to Test the Safety of Immunotherapy With Nivolumab Alone or With Ipilimumab Before Surgery for Bladder Cancer Patients Who Are Not Suitable for Chemotherapy
📍 Memorial Sloan Kettering Basking Ridge (All Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant
📍 University of Texas MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔3 Tesla MRI in Patients With Bladder Cancer
📍 Ohio State University Medical Center — Columbus, Ohio
View Study & Checklist ➔REtrieval of Transurethrally Resected Intact En-bloc Vesical Tumors Using a Retrieval Device for Bladder Tumors
📍 Department of Urology, Aarhus University Hospital, Aarhus — Aarhus,
View Study & Checklist ➔Enhancing Patient Comfort and Reducing Anxiety During Flexible Cystoscopy and Bladder Instillation in Bladder Cancer Patients: A Randomized Controlled Trial and Observational Study
📍 Victoria Hospital - London Health Sciences Center — London, Ontario
View Study & Checklist ➔Imaging Study of [89Zr]DFO-YS5 for Cancer Detection
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer
📍 Massachussetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔Exploring Engagement Dynamics Among Individuals Impacted by Bladder Cancer
📍 Power Life Sciences — San Francisco, California
View Study & Checklist ➔Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy
📍 University of Chicago Medicine Comprehensive Cancer Center — Chicago, Illinois
View Study & Checklist ➔Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
📍 University of Kansas Medical Center — Kansas City, Kansas
View Study & Checklist ➔En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC
📍 University of Iowa — Iowa City, Iowa
View Study & Checklist ➔